330 related articles for article (PubMed ID: 29402276)
1. Establishment of a yeast-based VLP platform for antigen presentation.
Wetzel D; Rolf T; Suckow M; Kranz A; Barbian A; Chan JA; Leitsch J; Weniger M; Jenzelewski V; Kouskousis B; Palmer C; Beeson JG; Schembecker G; Merz J; Piontek M
Microb Cell Fact; 2018 Feb; 17(1):17. PubMed ID: 29402276
[TBL] [Abstract][Full Text] [Related]
2. Display of malaria transmission-blocking antigens on chimeric duck hepatitis B virus-derived virus-like particles produced in Hansenula polymorpha.
Wetzel D; Chan JA; Suckow M; Barbian A; Weniger M; Jenzelewski V; Reiling L; Richards JS; Anderson DA; Kouskousis B; Palmer C; Hanssen E; Schembecker G; Merz J; Beeson JG; Piontek M
PLoS One; 2019; 14(9):e0221394. PubMed ID: 31483818
[TBL] [Abstract][Full Text] [Related]
3. Bioprocess optimization for purification of chimeric VLP displaying BVDV E2 antigens produced in yeast Hansenula polymorpha.
Wetzel D; Barbian A; Jenzelewski V; Schembecker G; Merz J; Piontek M
J Biotechnol; 2019 Dec; 306():203-212. PubMed ID: 31634510
[TBL] [Abstract][Full Text] [Related]
4. Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice.
Arora U; Tyagi P; Swaminathan S; Khanna N
Vaccine; 2013 Jan; 31(6):873-8. PubMed ID: 23261049
[TBL] [Abstract][Full Text] [Related]
5. Production in Pichia pastoris and characterization of genetic engineered chimeric HBV/HEV virus-like particles.
Li HZ; Gang HY; Sun QM; Liu X; Ma YB; Sun MS; Dai CB
Chin Med Sci J; 2004 Jun; 19(2):78-83. PubMed ID: 15250239
[TBL] [Abstract][Full Text] [Related]
6. Chimeric Hepatitis B core virus-like particles harboring SARS-CoV2 epitope elicit a humoral immune response in mice.
Sazegari S; Akbarzadeh Niaki M; Afsharifar A; Niazi A; Derakhshandeh A; Moradi Vahdat M; Hemmati F; Eskandari MH
Microb Cell Fact; 2023 Feb; 22(1):39. PubMed ID: 36841778
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of Leishmania-derived hepatitis B small surface antigen particles exposing highly conserved E2 epitope of hepatitis C virus.
Czarnota A; Tyborowska J; Peszyńska-Sularz G; Gromadzka B; Bieńkowska-Szewczyk K; Grzyb K
Microb Cell Fact; 2016 Apr; 15():62. PubMed ID: 27075377
[TBL] [Abstract][Full Text] [Related]
8. Pichia pastoris-expressed Zika virus envelope domain III on a virus-like particle platform: design, production and immunological evaluation.
Shanmugam RK; Ramasamy V; Shukla R; Arora U; Swaminathan S; Khanna N
Pathog Dis; 2019 Apr; 77(3):. PubMed ID: 31093663
[TBL] [Abstract][Full Text] [Related]
9. Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties.
Liu Y; Zhou J; Yu Z; Fang D; Fu C; Zhu X; He Z; Yan H; Jiang L
BMC Microbiol; 2014 Dec; 14():233. PubMed ID: 25520151
[TBL] [Abstract][Full Text] [Related]
10. Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen.
Pleckaityte M; Bremer CM; Gedvilaite A; Kucinskaite-Kodze I; Glebe D; Zvirbliene A
BMC Biotechnol; 2015 Sep; 15():85. PubMed ID: 26370129
[TBL] [Abstract][Full Text] [Related]
11. A novel chimeric Hepatitis B virus S/preS1 antigen produced in mammalian and plant cells elicits stronger humoral and cellular immune response than the standard vaccine-constituent, S protein.
Dobrica MO; Lazar C; Paruch L; Skomedal H; Steen H; Haugslien S; Tucureanu C; Caras I; Onu A; Ciulean S; Branzan A; Clarke JL; Stavaru C; Branza-Nichita N
Antiviral Res; 2017 Aug; 144():256-265. PubMed ID: 28666757
[TBL] [Abstract][Full Text] [Related]
12. A virus-like particle of the hepatitis B virus preS antigen elicits robust neutralizing antibodies and T cell responses in mice.
Cai X; Zheng W; Pan S; Zhang S; Xie Y; Guo H; Wang G; Li Z; Luo M
Antiviral Res; 2018 Jan; 149():48-57. PubMed ID: 29129705
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
[TBL] [Abstract][Full Text] [Related]
14. Malaria vaccine candidates displayed on novel virus-like particles are immunogenic and induce transmission-blocking activity.
Chan JA; Wetzel D; Reiling L; Miura K; Drew DR; Gilson PR; Anderson DA; Richards JS; Long CA; Suckow M; Jenzelewski V; Tsuboi T; Boyle MJ; Piontek M; Beeson JG
PLoS One; 2019; 14(9):e0221733. PubMed ID: 31504038
[TBL] [Abstract][Full Text] [Related]
15. Recent advancements in combination subunit vaccine development.
Tan M; Jiang X
Hum Vaccin Immunother; 2017 Jan; 13(1):180-185. PubMed ID: 27649319
[TBL] [Abstract][Full Text] [Related]
16. Potato virus Y-like particles as a new carrier for the presentation of foreign protein stretches.
Kalnciema I; Skrastina D; Ose V; Pumpens P; Zeltins A
Mol Biotechnol; 2012 Oct; 52(2):129-39. PubMed ID: 22167454
[TBL] [Abstract][Full Text] [Related]
17. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
Vietheer PT; Boo I; Drummer HE; Netter HJ
Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
[TBL] [Abstract][Full Text] [Related]
18. Bacterial superglue generates a full-length circumsporozoite protein virus-like particle vaccine capable of inducing high and durable antibody responses.
Janitzek CM; Matondo S; Thrane S; Nielsen MA; Kavishe R; Mwakalinga SB; Theander TG; Salanti A; Sander AF
Malar J; 2016 Nov; 15(1):545. PubMed ID: 27825348
[TBL] [Abstract][Full Text] [Related]
19. Virus-like particle production with yeast: ultrastructural and immunocytochemical insights into Pichia pastoris producing high levels of the hepatitis B surface antigen.
Lünsdorf H; Gurramkonda C; Adnan A; Khanna N; Rinas U
Microb Cell Fact; 2011 Jun; 10():48. PubMed ID: 21703024
[TBL] [Abstract][Full Text] [Related]
20. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
Lyu K; He YL; Li HY; Chen R
J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]